Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Goodwill & Intangibles: 2010-2025

Historic Goodwill & Intangibles for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to $75.9 million.

  • OptimizeRx's Goodwill & Intangibles fell 3576.51% to $75.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.9 million, marking a year-over-year decrease of 3576.51%. This contributed to the annual value of $76.4 million for FY2024, which is 4073.74% down from last year.
  • According to the latest figures from Q3 2025, OptimizeRx's Goodwill & Intangibles is $75.9 million, which was down 3576.51% from $76.0 million recorded in Q2 2025.
  • OptimizeRx's Goodwill & Intangibles' 5-year high stood at $128.9 million during Q4 2023, with a 5-year trough of $14.7 million in Q1 2022.
  • Over the past 5 years, OptimizeRx's median Goodwill & Intangibles value was $36.6 million (recorded in 2022), while the average stood at $58.2 million.
  • Within the past 5 years, the most significant YoY rise in OptimizeRx's Goodwill & Intangibles was 39222.79% (2024), while the steepest drop was 4073.74% (2024).
  • OptimizeRx's Goodwill & Intangibles (Quarter) stood at $32.3 million in 2021, then soared by 37.97% to $44.5 million in 2022, then surged by 189.65% to $128.9 million in 2023, then tumbled by 40.74% to $76.4 million in 2024, then decreased by 0.66% to $75.9 million in 2025.
  • Its last three reported values are $75.9 million in Q3 2025, $76.0 million for Q2 2025, and $76.2 million during Q1 2025.